MyFinsight
Home
About
Contact
Back
Income Statement
SAB Biotherapeutics, Inc. (SABS)
source: myfinsight.com
Download
Download image
Net loss
-$10,114,270
Total other income
(expense)
-$382,209
Loss from operations
-$9,732,061
Interest income
$13,562
Other income
$295,630
Changes in fair value of
warrant liabilities
$627,056
Total operating
expenses
$9,732,061
Interest expense
$64,345
General and
administrative
$2,735,401
Research and development
$6,996,660
Back